Showing results (1181-1190 of 1,391) with videos related to

Sort By:
Pageof 140
Gastroenterology|October 1, 1988
Healing and relapse of severe peptic esophagitis after treatment with omeprazoleD J Hetzel, J Dent, W D Reed, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|July 29, 2021
Light chain deposition disease presenting as an atrial mass: a case report and review of literatureMadeline Hudak, Ruhani Sardana, Anil V Parwani, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 21, 2024
Understanding Breathlessness Burden and Psychophysiological Correlates in AsthmaHayley Lewthwaite, Peter G Gibson, Paola D Urroz Guerrero, et al.
The EMBO Journal|September 16, 2006
A CapG gain-of-function mutant reveals critical structural and functional determinants for actin filament severingY Zhang, Sergey M Vorobiev, Bruce G Gibson, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2007
IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbationsPeter A B Wark, Fabio Bucchieri, Sebastian L Johnston, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
One-step assembly in yeast of 25 overlapping DNA fragments to form a complete synthetic Mycoplasma genitalium genomeDaniel G Gibson, Gwynedd A Benders, Kevin C Axelrod, et al.
JMIR Research Protocols|May 7, 2017
Evaluation of Mechanisms to Improve Performance of Mobile Phone Surveys in Low- and Middle-Income Countries: Research ProtocolDustin G Gibson, George William Pariyo, Adaeze C Wosu, et al.
ERJ Open Research|April 28, 2020
Management of acute COPD exacerbations in Australia: do we follow the guidelines?Joyce L Cousins, Richard Wood-Baker, Peter A B Wark, et al.
The European Respiratory Journal|October 14, 2024
Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthmaYuto Hamada, Dennis Thomas, Erin S Harvey, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2022
Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic AsthmaVicky Kritikos, Erin S Harvey, Sean Stevens, et al.
Pageof 140